Study to determine absorption, metabolism, and excretion of [14C]-SAR439859, and to assess absolute oral bioavailability of amcenestrant (SAR439859), in healthy post-menopausal women

Trial Identifier: BEX15859
Sponsor: Sanofi
Start Date: June 2021
Primary Completion Date: August 2021
Study Completion Date: August 2021
Condition: Breast Cancer; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United Kingdom Nottingham, United Kingdom, NG11 6JS